Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study

Title: Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study
Authors: Fianchi L.; Piciocchi A.; Guolo F.; Marchesi F.; Marsili G.; Cattaneo C.; Gottardi M.; Restuccia F.; Candoni A.; Ortu La Barbera E.; Fazzi R.; Pasciolla C.; Finizio O.; Fracchiolla N.; Delia M.; Lessi F.; Dargenio M.; Bonuomo V.; Del Principe M. I.; Zappasodi P.; Picardi M.; Basilico C.; Piedimonte M.; Minetto P.; Chiusolo P.; Prezioso L.; Buquicchio C.; Melillo L.; Zama D.; Farina F.; Mancini V.; Rondoni M.; Busca A.; Pagano L.
Contributors: Fianchi, L.; Piciocchi, A.; Guolo, F.; Marchesi, F.; Marsili, G.; Cattaneo, C.; Gottardi, M.; Restuccia, F.; Candoni, A.; Ortu La Barbera, E.; Fazzi, R.; Pasciolla, C.; Finizio, O.; Fracchiolla, N.; Delia, M.; Lessi, F.; Dargenio, M.; Bonuomo, V.; Del Principe, M. I.; Zappasodi, P.; Picardi, M.; Basilico, C.; Piedimonte, M.; Minetto, P.; Chiusolo, P.; Prezioso, L.; Buquicchio, C.; Melillo, L.; Zama, D.; Farina, F.; Mancini, V.; Rondoni, M.; Busca, A.; Pagano, L.
Publication Year: 2025
Collection: IRIS Università degli Studi di Bologna (CRIS - Current Research Information System)
Subject Terms: CPX- 351; Matching-adjusted indirect comparison; Secondary acute myeloid leukemia
Description: A real-life study on CPX-351 and the standard arm (‘7 + 3’) of the CPX-351 registrative trial in adults with secondary Acute Myeloid Leukemia were compared by an unanchored Matching-adjusted indirect comparison (MAIC), in order to evaluate the efficacy and toxicity of CPX-351. Results of this study are important to confirm the role of CPX-351 in significantly improving survival and remission rates compared with ‘7 + 3’ with a good safety profile in AML patients with high-risk features, a target group traditionally with a very poor prognosis. Moreover, this pilot analysis underlines the potentiality of the statistical method to compare studies with strong differences.
Document Type: article in journal/newspaper
File Description: ELETTRONICO
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/40411596; info:eu-repo/semantics/altIdentifier/wos/WOS:001493606500001; volume:104; issue:5; firstpage:2731; lastpage:2736; numberofpages:6; journal:ANNALS OF HEMATOLOGY; https://hdl.handle.net/11585/1030573
DOI: 10.1007/s00277-025-06381-3
Availability: https://hdl.handle.net/11585/1030573; https://doi.org/10.1007/s00277-025-06381-3; https://link.springer.com/article/10.1007/s00277-025-06381-3
Rights: info:eu-repo/semantics/openAccess ; license:Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY) ; license uri:iris.PUB15
Accession Number: edsbas.1A5243BC
Database: BASE